OLOPATADINE HCL- olopatadine hcl solution/ drops 
Sola Pharmaceuticals

----------

Olopatadine Hcl

Active Ingredient

Olopatadine (0.1%)

(equivalent to olopatadine hydrochloride, USP 0.111%)

Purpose

Antihistamine and redness reliever

Uses

Temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander

Warnings

For external use only

Do not use

When using this product

Stop use and ask a doctor if you experience:

Keep our of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

consult a doctor​

Other information

Inactive ingredients

benzalkonium chloride 0.01%, dibasic sodium phosphate, hydrochloric acid/sodium hydroxide (to adjust pH), sodium chloride and water for injection

Questions?

Call 1-866-747-7365

Principle Display Panel

Manufactured for:

SOLA Pharmaceuticals LLC,

Baton Rouge, LA 70810

Made in India

Code No: DD/DRUGS/DD/292

Olopatadine Hcl Opthalmic Solution 0.1% Bottle Label:

Bottle Label

Olopatadine Hcl Opthalmic Solution 0.1% Carton Label:

Carton Label

OLOPATADINE HCL 
olopatadine hcl solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70512-520
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OLOPATADINE HYDROCHLORIDE (UNII: 2XG66W44KF) (OLOPATADINE - UNII:D27V6190PM) OLOPATADINE HYDROCHLORIDE1 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70512-520-051 in 1 CARTON07/05/2022
15 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20315207/05/2022
Labeler - Sola Pharmaceuticals (080121345)

Revised: 11/2023
Document Id: 0a4bd65a-f2eb-7ab9-e063-6394a90a9dae
Set id: e314e745-1e83-a530-e053-2995a90a67b4
Version: 3
Effective Time: 20231116
 
Sola Pharmaceuticals